696 related articles for article (PubMed ID: 32780287)
1. NOX Inhibitors: From Bench to Naxibs to Bedside.
Elbatreek MH; Mucke H; Schmidt HHHW
Handb Exp Pharmacol; 2021; 264():145-168. PubMed ID: 32780287
[TBL] [Abstract][Full Text] [Related]
2. Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.
Touyz RM; Anagnostopoulou A; Camargo LL; Rios FJ; Montezano AC
Antioxid Redox Signal; 2019 Mar; 30(7):1027-1040. PubMed ID: 30334629
[TBL] [Abstract][Full Text] [Related]
3. Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation.
Dao VT; Elbatreek MH; Altenhöfer S; Casas AI; Pachado MP; Neullens CT; Knaus UG; Schmidt HHHW
Free Radic Biol Med; 2020 Feb; 148():60-69. PubMed ID: 31883469
[TBL] [Abstract][Full Text] [Related]
4. Mammalian NADPH Oxidases.
Buvelot H; Jaquet V; Krause KH
Methods Mol Biol; 2019; 1982():17-36. PubMed ID: 31172464
[TBL] [Abstract][Full Text] [Related]
5. Nox, Nox, Are You There? The Role of NADPH Oxidases in the Peripheral Nervous System.
Eid SA; Savelieff MG; Eid AA; Feldman EL
Antioxid Redox Signal; 2022 Sep; 37(7-9):613-630. PubMed ID: 34861780
[No Abstract] [Full Text] [Related]
6. Redox regulation of Nox proteins.
Pendyala S; Natarajan V
Respir Physiol Neurobiol; 2010 Dec; 174(3):265-71. PubMed ID: 20883826
[TBL] [Abstract][Full Text] [Related]
7. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.
Kawahara T; Ritsick D; Cheng G; Lambeth JD
J Biol Chem; 2005 Sep; 280(36):31859-69. PubMed ID: 15994299
[TBL] [Abstract][Full Text] [Related]
8. Oxidants in Physiological Processes.
Knaus UG
Handb Exp Pharmacol; 2021; 264():27-47. PubMed ID: 32767144
[TBL] [Abstract][Full Text] [Related]
9. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.
Bedard K; Krause KH
Physiol Rev; 2007 Jan; 87(1):245-313. PubMed ID: 17237347
[TBL] [Abstract][Full Text] [Related]
10. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
11. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.
Lassègue B; Sorescu D; Szöcs K; Yin Q; Akers M; Zhang Y; Grant SL; Lambeth JD; Griendling KK
Circ Res; 2001 May; 88(9):888-94. PubMed ID: 11348997
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.
Frey RS; Ushio-Fukai M; Malik AB
Antioxid Redox Signal; 2009 Apr; 11(4):791-810. PubMed ID: 18783313
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.
Rezende F; Prior KK; Löwe O; Wittig I; Strecker V; Moll F; Helfinger V; Schnütgen F; Kurrle N; Wempe F; Walter M; Zukunft S; Luck B; Fleming I; Weissmann N; Brandes RP; Schröder K
Free Radic Biol Med; 2017 Jan; 102():57-66. PubMed ID: 27863990
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies.
Sylvester AL; Zhang DX; Ran S; Zinkevich NS
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740948
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 4 and its role in the cardiovascular system.
Gray SP; Shah AM; Smyrnias I
Vasc Biol; 2019; 1(1):H59-H66. PubMed ID: 32923955
[TBL] [Abstract][Full Text] [Related]
17. Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".
Dahan I; Pick E
Cell Mol Life Sci; 2012 Jul; 69(14):2283-305. PubMed ID: 22562603
[TBL] [Abstract][Full Text] [Related]
18. Methods for Detection of NOX-Derived Superoxide Radical Anion and Hydrogen Peroxide in Cells.
Augsburger F; Filippova A; Jaquet V
Methods Mol Biol; 2019; 1982():233-241. PubMed ID: 31172475
[TBL] [Abstract][Full Text] [Related]
19. Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond GR; Sobey CG
Trends Endocrinol Metab; 2014 Sep; 25(9):452-63. PubMed ID: 25066192
[TBL] [Abstract][Full Text] [Related]
20. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
Altenhöfer S; Kleikers PW; Radermacher KA; Scheurer P; Rob Hermans JJ; Schiffers P; Ho H; Wingler K; Schmidt HH
Cell Mol Life Sci; 2012 Jul; 69(14):2327-43. PubMed ID: 22648375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
